EGFR and neoplasm: For example, the combination of PD-1/L1 blockade and inhibition of CD73 [12], IL-6 [13], ILT4 [14], PKCδ [15], or CD55/CD59 [16] has been shown to inhibit EGFR-mutated tumor growth in animal models.